We are looking forward to spending time with our colleagues at the Westin Waltham Boston for MSCO's 2024 Annual Meeting. This year's event will provide an opportunity to learn, reconnect, and enjoy being with one another. This evening event will include a schedule of state legislative updates, awards and the latest research that support the advancement of exemplary care for Massachusetts patients.
AGENDA
Join us for an engaging meeting agenda that features cutting-edge research presentations and legislative updates designed to benefit everyone involved in cancer care, including clinicians, providers, support staff, patients, and caretakers, ensuring a comprehensive and inclusive experience.
This Conference is a great opportunity to:
- Learn insights into the current state of oncology legislation in Massachusetts.
- Find out about exciting developments in the treatment of cancer.
- Exchange valuable insights.
- Expand your professional and care network.
View Agenda >
AWARDS
MSCO is proud to recognize individuals and organizations who make substantial contributions and impacts to the field of oncology and patient care within the state.
- Arthur T. Skarin Award - Caroline C. Block, MD
- Audesse Award - Helping Our Women
- Distinguished Researcher Award - Geoffrey I. Shapiro, MD, PhD
GRANTS
MSCO is investing in the future of oncology by supporting the professional development and research of young clinicians and trainees in Massachusetts.
- Young Investigator Award (YIA) Recipient - Leon Pappas, MD, PhD
- MSCO Cancer Survivorship Research Grant - Mary C. Boulanger, MD
POSTER COMPETITION
This is a unique opportunity for trainees in Massachusetts to present your work, gain recognition, and be celebrated within the state oncology community during our annual meeting.
Learn More >
SPONSORS
DIAMOND: Bristol Myers Squibb, Exact Sciences, Incyte, Jazz Pharmaceuticals, Regeneron, Rigel, Stemline
PLATINUM: AbbVie, Amgen, Astellas, AstraZeneca, AVEO Oncology, Boehringer Ingelheim, Daiichi-Sankyo, Eisai, Exelixis, Genentech, Genmab, Gilead, GSK, Janssen Johnson & Johnson, Merck, Pfizer, Pharmacyclics, Servier
GOLD: Bayer, Blueprint Medicines, Karyopharm Therapeutics, Foundation Medicine, Lilly Oncology, Novartis, Sanofi, Sumitomo Pharma, Takeda Oncology
